Tuberculosis — metabolism and respiration in the absence of growth
The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Human tuberculosis is a complex disease caused by bacterial populations that are located in discrete lesions (microenvironments) in a single host. Some of these microenvironments are conducive to replication, whereas others restrict bacterial growth without necessarily sterilizing the infecting microorganisms. The physical and biochemical milieu in these lesions is poorly defined. None of the existing animal models for tuberculosis (except perhaps non-human primates) reproduce the diversity of disease progression that is seen in humans. Nonetheless, transcriptomics and studies using bacterial mutants have led to testable hypotheses about metabolic functions that are essential for viability in the absence of replication. A complete picture of bacterial metabolism must balance reducing equivalents while maintaining an energized membrane and basic cellular processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“M. tuberculosis harbours genes for a cytochrome c pathway consisting of a menaquinol-cytochrome c oxidoreductase termed the bc1 complex (encoded by the qcrCAB operon, complex III) and an aa3-type cytochrome c oxidase (encoded by the genes ctaBCDE, complex IV) belonging to the heme-copper respiratory oxidase family (69–71) (Table 1).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [69]
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · cited 1×
“tuberculosis encodes four glucose-6-phosphate dehydrogenases — two of which require NADPH as the electron donor ( zwf1 , zwf2 ), whereas fgd1 and fgd2 encode F 420 -requiring dehydrogenase”
BackgroundSelf-citationExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“However, tumour cells are able to adjust their metabolism to adapt to anaerobic condition”
BackgroundThe Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469 · cited 1×
“3 ), whereas higher concentrations might reach other sensitive intracellular target”
BackgroundTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180 · cited 1×
“tuberculosis during the chronic stage of the disease in mice is largely dependent on production of nitric oxide and other REACTIVE NITROGEN INTERMEDIATES (RNI), with decreased production of RNIs leading to reactivation of diseas”
BackgroundWayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Research works printed but not linked: 4
- Jagirdar, J. & Zagzag, D. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 323–344 (Lippincott Williams & Wilkins, Philadelphia, 2004). A good current and historical overview of the pathology of different forms of tuberculosis in humans.
- Daley, C. L. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 85–99 (Lippincott Williams & Wilkins, Philadelphia, 2004).
- Condos, R. & Rom, W. N. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 285–299 (Lippincott Williams & Wilkins, Philadelphia, 2004).
- Garay, S. M. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 345–394 (Lippincott Williams & Wilkins, Philadelphia, 2004). A review of the clinical aspects of pulmonary tuberculosis with well-documented case studies of reactivation disease.
Cited by
Items 201–300 of 452
Microarray Analysis of Whole Genome Expression of Intracellular Mycobacterium tuberculosis
Waddell, S. J., & Butcher, P. D. (2007) · Current Molecular Medicine · doi:10.2174/156652407780598548 · Cited by 47
TuberQ: a Mycobacterium tuberculosis protein druggability database
Radusky, L., Defelipe, L. A., Lanzarotti, E., Luque, F. J., Barril, X., Marti, M. A., & Turjanski, A. G. (2014) · Database · doi:10.1093/database/bau035 · Cited by 40
Tudó, G., Laing, K. G., Mitchison, D. A., Butcher, P. D., & Waddell, S. J. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.219 · Cited by 41
Bioluminescence for Assessing Drug Potency against Nonreplicating Mycobacterium tuberculosis
Vocat, A., Hartkoorn, R. C., Lechartier, B., Zhang, M., Dhar, N., Cole, S. T., & Sala, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00528-15 · Cited by 43
“tuberculosis can enter a dormant or latent state characterized by reduced growth rate, limited metabolic activity, and phenotypic resistance to most currently available compounds (2, 3), thus making anti-TB treatment even more challenging.”
BackgroundNew drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
Leibert, E. M., Rom, W. N., & DANCKERS, M. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s37743 · Cited by 41
“While an organism might remain alive while not making cell walls, and even while synthesizing very little protein, it cannot maintain an electrified cell membrane gradient and survive.(20) It is estimated that one-third of the population is latently infected with M.”
Secretory Proteome Analysis of Streptomycin-Resistant Mycobacterium tuberculosis Clinical Isolates
Sharma, D., & Bisht, D. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217698428 · Cited by 37
“Rv0896 (citrate synthase 1) is involved in the tricarboxylic acid cycle that is the central metabolic pathway and responsible for the synthesis of many important precursors and molecules.(35) Overexpression of Rv0896 might maintain an energy supply to resistant M.”
BackgroundF420-dependent enzymes – potential for applications in biotechnology
Taylor, M. C., Scott, C. S., & Grogan, G. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.09.003 · Cited by 37
Guerrero‐Castillo, S., Cabrera‐Orefice, A., Vázquez‐Acevedo, M., González‐Halphen, D., & Uribe‐Carvajal, S. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.11.007 · Cited by 39
Rakesh, R., Bruhn, D. F., Scherman, M. S., Woolhiser, L. K., Madhura, D. B., Maddox, M. M., Singh, A. P., Lee, R. B., Hurdle, J. G., McNeil, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087909 · Cited by 36
“Therefore, it is imperative that novel antitubercular agents target these persisting bacterial subpopulations [6,7].”
Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis
Fang, X. D., Wallqvist, A., & Reifman, J. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-160 · Cited by 43
“Moreover, our additions of the uptakes of NO3 , O2, and Fe 3+ (see Table 3) were supported by the existence of NO3 in infected tissue [63], the detection of O2 in mouse lung granulomas [7,31], and the ability of M.”
BackgroundInfluentialIRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis
Shen, P., Li, Q., Ma, J., Tian, M., Hong, F., Zhai, X., Li, J., Huang, H., & Shi, C. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1095-2 · Cited by 36
“tb to host and pharmacological killing [39, 40].”
Rojony, R., Martin, M. T., Campeau, A., Wozniak, J. M., Gonzalez, D. J., Jaiswal, P., Danelishvili, L., & Bermudez, L. E. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9260-2 · Cited by 36
Novel drug target strategies against Mycobacterium tuberculosis
Murphy, D. J., & Brown, J. R. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.08.001 · Cited by 39
Даниленко, В. Н., Osolodkin, D. I., Александрович, Л. С., PREOBRAZHENSKAYA, M. N., & Shtil, A. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795589566 · Cited by 36
“It is generally accepted that the requirement for at least 6 months of treatment for active tuberculosis is due to the difficulty in eradicating a subpopulation of persistent forms [97].”
BackgroundHemsley, C. M., Luo, J. X., Andreae, C. A., Butler, C. S., Soyer, O. S., & Titball, R. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02793-14 · Cited by 36
“It has been shown that even nongrowing bacteria require some form of cellular energy and redox balance to stay viable (55).”
BackgroundBenard, E. L., Rougeot, J., Racz, P. I., Spaink, H. P., & Meijer, A. H. (2016) · Advances in genetics · doi:10.1016/bs.adgen.2016.04.004 · Cited by 41
“Hypoxia occurs in the environment of the human tuberculous granulomas and it may be responsible for M. tuberculosis dormancy (Boshoff & Barry, 2005).”
Background2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain
Jeon, A. B., Ackart, D. F., Li, W., Jackson, M., Melander, R. J., Melander, C., Abramovitch, R. B., Chicco, A. J., Basaraba, R. J., & Obregón‐Henao, A. (2019) · Scientific Reports · doi:10.1038/s41598-018-38064-7 · Cited by 37
Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress
Manina, G., Griego, A., Singh, L. K., McKinney, J. D., & Dhar, N. (2019) · The EMBO Journal · doi:10.15252/embj.2019101876 · Cited by 36
“In this critical phase of the cell cycle, replication forks are formed and ssDNA is more abundant and conceivably more vulnerable to the onset of intracellular alkylating and oxidative stress (Boshoff & Barry, 2005).”
Li, Q., Xie, Y., Cui, Z., Hai, H., Yang, H., Yuan, B., Shen, P., & Shi, C. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102044 · Cited by 36
Liu, X., Li, H., Qi, G., Qian, Y., Li, B., Shi, L., & Liu, B. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c09916 · Cited by 34
Tanner, L., Denti, P., Wiesner, L., & Warner, D. F. (2018) · IUBMB Life · doi:10.1002/iub.1866 · Cited by 36
Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis
Urban, M., Šlachtová, V., & Brulíková, L. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113139 · Cited by 37
Structures of citrate synthase and malate dehydrogenase of M ycobacterium tuberculosis
Ferraris, D. M., Spallek, R., Oehlmann, W., Singh, M., & Rizzi, M. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24743 · Cited by 34
Dynamic exometabolome analysis reveals active metabolic pathways in non‐replicating mycobacteria
Zimmermann, M., Kuehne, A., Boshoff, H. I., Barry, C. E., Zamboni, N., & Sauer, U. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.13056 · Cited by 37
Self-citationSupramolecular Organization in Prokaryotic Respiratory Systems
Magalon, A., Arias-Cartín, R., & Walburger, A. (2012) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/b978-0-12-394423-8.00006-8 · Cited by 35
Towards the stereochemical assignment of natural lydiamycin A
Chen, B., Dai, L., Zhang, H., Tan, W., Xu, Z., & Ye, T. (2009) · Chemical Communications · doi:10.1039/b922544g · Cited by 34
Tat–Dependent Translocation of an F420–Binding Protein of Mycobacterium tuberculosis
Bashiri, G., Perkowski, E. F., Turner, A., Feltcher, M. E., Braunstein, M., & Baker, E. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045003 · Cited by 38
“F420, with its low redox potential, may have a role in reactions associated with anaerobic survival [44].”
BackgroundChetnani, B., Kumar, P. R., Surolia, A., & Vijayan, M. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.064 · Cited by 36
Rossi, I., Buttini, F., Sonvico, F., Affaticati, F., Martinelli, F., Annunziato, G., Machado, D., Viveiros, M., Pieroni, M., & Bettini, R. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050203 · Cited by 32
“The difficult accessibility to the pharmacological target and the peculiar capability of Mtb to slow-down its metabolism and survive in a dormant state makes treatment of tuberculosis a challenging task [20].”
BackgroundKeshavjee, S. A., Amanullah, F., Cattamanchi, A., Chaisson, R. E., Dobos, K. M., Fox, G. J., Gendelman, H. E., Gordon, R. K., Hesseling, A. C., Van, H. L., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1053pp · Cited by 31
Nitrotriazole- and Imidazole-Based Amides and Sulfonamides as Antitubercular Agents
Papadopoulou, M. V., Bloomer, W. D., Rosenzweig, H. S., Arena, A., Arrieta, F., Rebolledo, J. C. J., & Smith, D. K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03644-14 · Cited by 31
“NRP TB fosters tolerance to many drugs and may explain the long treatment time required to eliminate infection (3).”
BackgroundZhou, M., Xie, L., Yang, Z., Zhou, J., & Xie, J. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1169219 · Cited by 31
Kolpen, M., Jensen, P. Ø., Qvist, T., Kragh, K. N., Ravnholt, C., Fritz, B. G., Johansen, U. R., Bjarnsholt, T., & Høiby, N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01212-19 · Cited by 30
“Mycobacterial growth has been shown to be O2 dependent, and therefore, ROS formation may provide an explanation for why MABSC quickly develops resistance to bactericidal drugs, such as aminoglycosides, during chronic lung infection in patients with CF (37).”
BackgroundHegde, S. R., Rajasingh, H., Das, C., Mande, S. S., & Mande, S. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033893 · Cited by 32
“An interesting aspect of dormancy is the communication between differentially regulated pathways [46,47].”
BackgroundInsight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase
Shukla, H., Kumar, V., Singh, A. K., Singh, N., Kashif, M., Siddiqi, M. I., Krishnan, M. Y., & Akhtar, M. S. (2015) · Biochimie · doi:10.1016/j.biochi.2014.12.016 · Cited by 28
Insights into the Physiology and Metabolism of a Mycobacterial Cell in an Energy-Compromised State
Patil, V., & Jain, V. P. (2019) · Journal of Bacteriology · doi:10.1128/jb.00210-19 · Cited by 28
“tuberculosis makes the eradication of this pathogen difficult (2, 3).”
BackgroundMetronidazole plus Rifampin Sterilizes Long-Term Dormant Mycobacterium tuberculosis
Iona, E., Giannoni, F., Pardini, M., Brunori, L., Orefici, G., & Fattorini, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01468-06 · Cited by 28
“colonies on agar (2), the samples for which results are shown in Fig.”
BackgroundOxygen and Nitrate Respiration in Streptomyces coelicolor A3(2)
Sawers, R. G., Falke, D., & Fischer, M. (2016) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2016.02.004 · Cited by 29
Jeong, J.-A., Park, S. W., Yoon, D., Kim, S., Kang, H.-Y., & Oh, J. (2018) · Journal of Bacteriology · doi:10.1128/jb.00152-18 · Cited by 29
“precursors under respiration-inhibitory conditions (6, 19, 21, 38).”
Hards, K., Adolph, C., Harold, L. K., McNeil, M. B., Cheung, C., Jinich, A., Rhee, K. Y., & Cook, G. M. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.11.003 · Cited by 30
Nikitushkin, V. D., Trenkamp, S., Demina, G. R., Shleeva, M. O., & Kaprelyants, A. S. (2020) · Metabolomics · doi:10.1007/s11306-020-1645-8 · Cited by 26
PhoY2 of Mycobacteria Is Required for Metabolic Homeostasis and Stress Response
Wang, C., Mao, Y., Yu, J., Zhu, L., Li, M., Wang, D., Dong, D., Liu, J., & Gao, Q. (2012) · Journal of Bacteriology · doi:10.1128/jb.01556-12 · Cited by 27
“tuberculosis to survive and persist under these stress conditions is thought to be essential for establishing long-term infection (2, 5).”
BackgroundModeling of Mycobacterium tuberculosis dormancy in bacterial cultures
Batyrshina, Y., & Schwartz, Y. S. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.05.005 · Cited by 29
Cytochrome bd oxidase: an emerging anti-tubercular drug target
Saha, P., Das, S., Indurthi, H. K., Kumar, R., Roy, A., Kalia, N. P., & Sharma, D. K. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00587a · Cited by 26
WhiB4 Regulates the PE/PPE Gene Family and is Essential for Virulence of Mycobacterium marinum
Wu, J., Ru, H.-W., Xiang, Z.-H., Jiang, J. H., Wang, Y., Zhang, L., & Liu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03020-4 · Cited by 27
CtpB is a plasma membrane copper (I) transporting P-type ATPase of Mycobacterium tuberculosis
León-Torres, A., Arango-Isaza, E., Castillo, E., & Soto, C. Y. (2020) · Biological Research · doi:10.1186/s40659-020-00274-7 · Cited by 27
Breda, A., Machado, P., Rosado, L. A., Souto, A. A., Santos, D. S., & Basso, L. A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.04.031 · Cited by 26
Snášel, J., Machová, I., Šolı́nová, V., Kašička, V., Krečmerová, M., & Pichová, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031483 · Cited by 25
“Metabolic flow through gluconeogenesis is necessary for Mtb infection and persistence in macrophages [16,17] and is indispensable for converting tricarboxylic acid cycle intermediates into sugars [18] when Mtb uses fatty acids as a carbon source.”
BackgroundAbhale, Y. K., Deshmukh, K. K., Sasane, A. V., Chavan, A., & Mhaske, P. C. (2015) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2409 · Cited by 26
Somasundaram, S., Santhaseela, A. R., Venkatesan, P., & Paramasivan, C. N. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-218 · Cited by 25
Gopinath, K., Kaiser, P., Constant, P., Abed, U. A., Schmid, M., Frese, C. K., Brinkmann, V., Daffé, M., & Kaufmann, S. H. E. (2021) · mBio · doi:10.1128/mbio.01665-21 · Cited by 24
“which is critical for the regeneration of reduced cofactors by fermentation (9, 23).”
BackgroundMoopanar, K. R., & Mvubu, N. E. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104250 · Cited by 25
Mutational Analysis of the Respiratory Nitrate Transporter NarK2 of Mycobacterium tuberculosis
Giffin, M. M., Raab, R. W., Morganstern, M., & Sohaskey, C. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045459 · Cited by 26
Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria
Cook, G. M., Hards, K., Vilchèze, C., Hartman, T. E., & Berney, M. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch20 · Cited by 24
Central Metabolism of Species of the Genus Rhodococcus
Álvarez, H. M. (2010) · Microbiology monographs · doi:10.1007/978-3-642-12937-7_4 · Cited by 23
Chopra, S., Koolpe, G. A., Tambo-ong, A., Matsuyama, K., Ryan, K. J., Tran, T. B., Doppalapudi, R. S., Riccio, E. S., Iyer, L., Green, C. E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300123s · Cited by 23
Gutka, H. J., Rukseree, K., Wheeler, P. R., Franzblau, S. G., & Movahedzadeh, F. (2011) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-011-9219-x · Cited by 23
Pang, H., Lilla, E. A., Zhang, P., Zhang, D., Shields, T. P., Scott, L. G., Yang, W., & Yokoyama, K. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01200 · Cited by 22
Saha, P., Sau, S., Kumar, R., Kalia, N. P., & Kumar, D. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00118d · Cited by 25
Malherbe, S. T., Dupont, P. J., Kant, I. M. J., Ahlers, P., Kriel, M., Loxton, A. G., Chen, R. Y., Via, L. E., Thienemann, F., Wilkinson, R. J., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0411-7 · Cited by 22
Self-citationChallenges in targeting mycobacterial ATP synthase: The known and beyond
Mapari, M. A., Bhole, R. P., Khedekar, P. B., & Chikhale, R. V. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131331 · Cited by 22
Shi, L., Sohaskey, C. D., North, R. J., & Gennaro, M. L. (2007) · Tuberculosis · doi:10.1016/j.tube.2007.08.007 · Cited by 25
An N-acyl homolog of mycothiol is produced in marine actinomycetes
Newton, G. L., Jensen, P. R., MacMillan, J. B., Fenical, W., & Fahey, R. C. (2008) · Archives of Microbiology · doi:10.1007/s00203-008-0405-3 · Cited by 23
“Degradation of odd chain and branched fatty acids (BoshoV and Barry 2005; Koburger et al. 2005) and of cholesterol (Pandey and Sassetti 2008) leads to the production of propionyl-CoA, as does growth in the presence of propionate (Brock and Buckel 2004).”
Wang, E., Ikonen, T. P., Knaapila, M., Svergun, D. I., Logan, D. T., & von Wachenfeldt, C. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.02.050 · Cited by 21
“The ability of aerobic bacteria to sense and rapidly adapt to changes in the supply of oxygen in their environment is key to survival and persistence.(1,2) Molecular oxygen acts as the terminal electron acceptor in oxidative phosphorylation, and bacteria have evolved mechanisms to sense and respond to variations in ox…”
BackgroundMicrobiological and immunological diagnosis of tuberculous spondylodiscitis.
Delogu, G., Zumbo, A., & Fadda, G. (2012) · PubMed · Cited by 24
Sun, X. L., Zhang, L., Jiang, J. H., Ng, M. C. W., Cui, Z., Mai, J., Ahn, S. K., Liu, J., Zhang, J., Liu, J., et al. (2018) · Virulence · doi:10.1080/21505594.2018.1514237 · Cited by 23
Breda, A., Rosado, L. A., Lorenzini, D. M., Basso, L. A., & Santos, D. S. (2011) · Molecular BioSystems · doi:10.1039/c1mb05402c · Cited by 21
Shotgun proteomic profiling of dormant, ‘non-culturable’ Mycobacterium tuberculosis
Nikitushkin, V. D., Shleeva, M. O., Loginov, D. S., Dyčka, F., Štěrba, J., & Kaprelyants, A. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269847 · Cited by 23
“The subunits of membrane-bound fumarate reductase were not technically detected; however, subunits of the succinate dehydrogenase complex (Rv3318 and Rv0247c) were detected, potentially enabling the reverse flow of the processes in the ‘reductive branch’ of the TCA cycle (part of the Arnon–Buchanan cycle) from pyruvat…”
BackgroundInfluentialTargeting the global regulator Lsr2 as a novel approach for anti-tuberculosis drug development
Liu, J., & Gordon, B. R. G. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.86 · Cited by 20
Nguyen, N. H., Wilson, D. W., Nagalingam, G., Triccas, J. A., Schneider‐Futschik, E. K., Li, J., Velkov, T., & Baell, J. B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.010 · Cited by 20
Metabolomics: A window into the adaptive physiology of Mycobacterium tuberculosis
Eoh, H. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.08.002 · Cited by 22
New drugs and regimens for treatment of TB
Leibert, E. M., & Rom, W. N. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.60 · Cited by 24
Roles of Lipolytic enzymes in Mycobacterium tuberculosis pathogenesis
Lin, H., Xing, J., Wang, H., Wang, S., Ren, F., Li, X., Li, Z., & Song, N. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1329715 · Cited by 21
The preprotein translocase YidC controls respiratory metabolism in Mycobacterium tuberculosis
Thakur, P., Gantasala, N. P., Choudhary, E., Singh, N., Abdin, M. Z., & Agarwal, N. (2016) · Scientific Reports · doi:10.1038/srep24998 · Cited by 23
Mashalidis, E. H., Gittis, A. G., Tomczak, A., Abell, C., Barry, C. E., & Garboczi, D. N. (2015) · Protein Science · doi:10.1002/pro.2645 · Cited by 19
“Coenzyme F420 has a lower reduction potential (E 2360 mV)(11) than most flavins and it has been suggested that this redox chemistry may help the bacterium survive in anaerobic conditions existing in human lesions.(12) Little is known about the enzymes in Mtb that”
BackgroundSelf-citationAtypical growth of Renibacterium salmoninarum in subclinical infections
Hirvelä-Koski, V., Pohjanvirta, T., Koski, P., & Sukura, A. (2005) · Journal of Fish Diseases · doi:10.1111/j.1365-2761.2005.00677.x · Cited by 25
Xia, K., Shen, G., & Zhu, X. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00538h · Cited by 19
Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice
McDaniel, M. M., Krishna, N., V, Handagama, W., Eda, S., & Ganusov, V. V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00862 · Cited by 20
“…of mouse Frontiers in Microbiology | www.frontiersin.org 2 June 2016 | Volume 7 | Article 862 lung histopathology during chronic infection have indicated deterioration of tissue health and progressive inflammation, despite stable bacterial counts (Rhoades et al., 1997; Boshoff and Barry, 2005).”
BackgroundResultContribution of high‐content imaging technologies to the development of anti‐infective drugs
Ang, M. L. T., & Pethe, K. (2016) · Cytometry Part A · doi:10.1002/cyto.a.22885 · Cited by 19
“tuberculosis is a facultative intracellular pathogen, it is well recognized that intracellular mycobacteria are phenotypically resistant to a wide variety of antibiotics (8,9), making them recalcitrant to drug treatment.”
BackgroundBioenergetic Heterogeneity in Mycobacterium tuberculosis Residing in Different Subcellular Niches
Akela, A. K., & Kumar, A. (2021) · mBio · doi:10.1128/mbio.01088-21 · Cited by 17
“state of Mycobacterium tuberculosis (Mtb) (7).”
Erol, A. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.03.028 · Cited by 18
Gutka, H. J., Wang, Y., Franzblau, S. G., & Movahedzadeh, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138436 · Cited by 18
“Mtb grows on a variety of substrates in vitro but mounting evidence indicates that during infection most of its energy is derived from fatty acids [1, 2].”
BackgroundAcademy of Science of South Africa (ASSAf) (2007) · doi:10.17159/assaf/0037 · Cited by 33
Sengupta, S., Naz, S., Das, I., Ahad, A., Padhi, A., Naik, S. K., Ganguli, G., Pattanaik, K. P., Raghav, S. K., Nandicoori, V. K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775205 · Cited by 17
RetractedZhang, J., Hu, L., Zhang, H., & He, Z. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.15987 · Cited by 17
An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis
Kelam, L. M., Wani, M. A., & Dhaked, D. K. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.04.009 · Cited by 19
Chutoam, P., Charoensawan, V., Wongtrakoongate, P., Kum‐arth, A., Buphamalai, P., & Tungpradabkul, S. (2013) · Microbiology and Immunology · doi:10.1111/1348-0421.12077 · Cited by 17
Alanine dehydrogenases in mycobacteria
Jeong, J.-A., & Oh, J. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-8543-7 · Cited by 17
2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium tuberculosis
Saha, P., Sau, S., Kalia, N. P., & Sharma, D. K. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00710 · Cited by 18
Ascensao, J. A., Datta, P., Hancioglu, B., Sontag, E. D., Gennaro, M. L., & Igoshin, O. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004741 · Cited by 16
Xu, J., Zhao, L., Liu, X., Hu, H., Liu, P., Tan, M., & Ye, B. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00213 · Cited by 17
Kilinç, G., Boland, R., Heemskerk, M. T., Spaink, H. P., Haks, M. C., van der Vaart, M., Ottenhoff, T. H. M., Meijer, A. H., & Saris, A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00167-24 · Cited by 16
Automated Diagnosis and Phenotyping of Tuberculosis Using Serum Metabolic Fingerprints
Liu, Y., Wang, R., Zhang, C., Huang, L., Chen, J., Zeng, Y., Chen, H., Wang, G., Qian, K., & Huang, P. (2024) · Advanced Science · doi:10.1002/advs.202406233 · Cited by 16
Pang, H., & Yokoyama, K. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.04.014 · Cited by 15
“Moco biosynthesis is also found essential for virulence of several clinically important bacterial pathogens, such as Mycobacterium tuberculosis (Boshoff & Barry, 2005) and Pseudomonas aeruginosa (Folkesson et al., 2012).”
BackgroundLopes, L. G. D. F., Carvalho, E. M., & Sousa, E. H. S. (2020) · Dalton Transactions · doi:10.1039/d0dt01365j · Cited by 15
Cook, G. M., Hards, K., Dunn, E. A., Heikal, A., Nakatani, Y., Greening, C., Crick, D. C., Fontes, F. L., Pethe, K., Hasenoehrl, E., et al. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch14 · Cited by 18
Hampel, A., Huber, C., Geffers, R., Spona-Friedl, M., Eisenreich, W., & Bange, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136914 · Cited by 15
Abdou, E., de Bagüés, M. P. J., Martínez-Abadía, I., Ouahrani‐Bettache, S., Pantesco, V., Occhialini, A., Dahouk, S. A., Köhler, S., & Jubier-Maurin, V. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00186 · Cited by 15
Mass spectrometry-based metabolomics for tuberculosis meningitis
Zhang, P., Zhang, W., Lang, Y., Qu, Y., Chu, F., Chen, J., & Cui, L. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.022 · Cited by 18
Corrêa, A. F., Bailão, A. M., Bastos, I. M. D., Orme, I. M., Soares, C. M. A., Kipnis, A., Santana, J. M., & Junqueira‐Kipnis, A. P. (2014) · Infection and Immunity · doi:10.1128/iai.02304-14 · Cited by 14
“Further, ET-1 could be involved in decreased oxygen tension or hypoxia described in granulomas undergoing caseous necrosis and characterized by a lack of vascularity in human tissue (58).”
Background
Metadata
- Authors
- Boshoff, H. I. M., & Barry, C. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Boshoff, Helena I. M.
- Venue
- Nature Reviews Microbiology
- Published
- 2005-01
- Volume
- 3
- Issue
- 1
- Pages
- 70-80
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1973789730
- Cited by
- 448
- References
- 88
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 11 · 2023: 11 · 2022: 9 · 2021: 17 · 2020: 20 · 2019: 22 · 2018: 21 · 2017: 22 · 2016: 20 · 2015: 35 · 2014: 30 · 2013: 24 · 2012: 26
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI000783)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis, Mycobacterium tuberculosis, bacterial metabolism, respiration, non-replicating persistence, animal models of tuberculosis, transcriptomics, bacterial mutants, reducing equivalents, membrane potential, bacterial viability
- MeSH terms
- Adaptation, Physiological, Animals, Citric Acid Cycle, Gluconeogenesis, Humans, Mycobacterium tuberculosis, Oxidation-Reduction, Oxygen Consumption, Riboflavin, Tuberculosis, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.